Another transgenic mouse, which features diabetes and impaired glucose-stimulated insulin secretion as a result of defective expression of hepatocyte nuclear factors, showed reduced islet expression of E-cadherin [188, 189]. The gene discussed is INS; the disease is diabetes mellitus.